Literature DB >> 28233681

Implementing an overdose education and naloxone distribution program in a health system.

Jennifer Devries, Sally Rafie, Gregory Polston.   

Abstract

OBJECTIVE: To design and implement a health system-wide program increasing provision of take-home naloxone in patients at risk for opioid overdose, with the downstream aim of reducing fatalities. The program includes health care professional education and guidelines, development, and dissemination of patient education materials, electronic health record changes to promote naloxone prescriptions, and availability of naloxone in pharmacies.
SETTING: Academic health system, San Diego, California. PRACTICE DESCRIPTION: University of California, San Diego Health (UCSDH), offers both inpatient and outpatient primary care and specialty services with 563 beds spanning 2 hospitals and 6 pharmacies. UCSDH is part of the University of California health system, and it serves as the county's safety net hospital. PRACTICE INNOVATION: In January 2016, a multisite academic health system initiated a system-wide overdose education and naloxone distribution program to prevent opioid overdose and opioid overdose-related deaths. An interdisciplinary, interdepartmental team came together to develop and implement the program. To strengthen institutional support, naloxone prescribing guidelines were developed and approved for the health system. Education on naloxone for physicians, pharmacists, and nurses was provided through departmental trainings, bulletins, and e-mail notifications. Alerts in the electronic health record and preset naloxone orders facilitated co-prescribing of naloxone with opioid prescriptions. EVALUATION: Electronic health record reports captured naloxone prescriptions ordered. Summary reports on the electronic health record measured naloxone reminder alerts and response rates.
RESULTS: Since the start of the program, the health system has trained 252 physicians, pharmacists, and nurses in overdose education and take-home naloxone. There has been an increase in the number of prescriptions for naloxone from a baseline of 4.5 per month to an average of 46 per month during the 3 months following full implementation of the program including implementation of electronic health record alerts.
CONCLUSION: Initiating and implementing an overdose education and naloxone distribution program is feasible in an academic health system.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28233681     DOI: 10.1016/j.japh.2017.01.002

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  12 in total

1.  Naloxone perspectives from people who use opioids: Findings from an ethnographic study in three states.

Authors:  Miriam Boeri; Aukje K Lamonica
Journal:  J Am Assoc Nurse Pract       Date:  2020-04-01       Impact factor: 1.165

2.  Development and evaluation of a pilot overdose education and naloxone distribution program for hospitalized general medical patients.

Authors:  Andrea Jakubowski; Alexander Pappas; Lee Isaacsohn; Felipe Castillo; Mariya Masyukova; Richard Silvera; Louisa Holaday; Evan Rausch; Sameen Farooq; Keith T Veltri; Chinazo O Cunningham; Marcus A Bachhuber
Journal:  Subst Abus       Date:  2018-11-26       Impact factor: 3.716

3.  Pediatric Provider Utilization of a Clinical Decision Support Alert and Association with HIV Pre-exposure Prophylaxis Prescription Rates.

Authors:  Carrie T Chan; Megen Vo; Jennifer Carlson; Tzielan Lee; Marcello Chang; Geoffrey Hart-Cooper
Journal:  Appl Clin Inform       Date:  2022-01-12       Impact factor: 2.342

4.  Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program.

Authors:  Robin A Pollini; Susannah Slocum; Jenny E Ozga; Rebecca Joyce; Ziming Xuan; Traci C Green; Alexander Y Walley
Journal:  J Am Pharm Assoc (2003)       Date:  2022-03-19

5.  Costs of opioid overdose education and naloxone distribution in New York City.

Authors:  Czarina N Behrends; Sarah Gutkind; Emily Winkelstein; Monique Wright; Jennifer Dolatshahi; Alice Welch; Denise Paone; Hillary V Kunins; Bruce R Schackman
Journal:  Subst Abus       Date:  2021-10-19       Impact factor: 3.984

6.  Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review.

Authors:  Emily Behar; Rita Bagnulo; Phillip O Coffin
Journal:  Prev Med       Date:  2018-06-15       Impact factor: 4.018

7.  Examining Factors Associated with Non-Fatal Overdose among People Who Inject Drugs in Rural Appalachia.

Authors:  Janet K Otachi; Nikita Vundi; Hilary L Surratt
Journal:  Subst Use Misuse       Date:  2020-06-19       Impact factor: 2.362

8.  The Emergency Department as an Opportunity for Naloxone Distribution.

Authors:  Alexander H Gunn; Zachary P W Smothers; Nicole Schramm-Sapyta; Caroline E Freiermuth; Mark MacEachern; Andrew J Muzyk
Journal:  West J Emerg Med       Date:  2018-09-10

9.  Pharmacist Services in the Opioid Crisis: Current Practices and Scope in the United States.

Authors:  Tanvee Thakur; Meredith Frey; Betty Chewning
Journal:  Pharmacy (Basel)       Date:  2019-06-13

10.  Evaluation of an interprofessional naloxone didactic and skills session with medical residents and physician assistant learners.

Authors:  Daniel Hargraves; Christopher C White; Marcia R Mauger; Aruna Puthota; Harini Pallerla; Patricia Wigle; Sarah L Brubaker; Jeffrey D Schlaudecker
Journal:  Pharm Pract (Granada)       Date:  2019-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.